341 related articles for article (PubMed ID: 29166921)
1. Identification of epidermal growth factor receptor-positive glioblastoma using lipid-encapsulated targeted superparamagnetic iron oxide nanoparticles in vitro.
Chen HL; Hsu FT; Kao YJ; Liu HS; Huang WZ; Lu CF; Tsai PH; Ali AAA; Lee GA; Chen RJ; Chen CY
J Nanobiotechnology; 2017 Nov; 15(1):86. PubMed ID: 29166921
[TBL] [Abstract][Full Text] [Related]
2. Detection of PD-L1 Expression in Temozolomide-Resistant Glioblastoma by Using PD-L1 Antibodies Conjugated with Lipid‑Coated Superparamagnetic Iron Oxide.
Lee GA; Lin WL; Kuo DP; Li YT; Chang YW; Chen YC; Huang SW; Hsu JB; Chen CY
Int J Nanomedicine; 2021; 16():5233-5246. PubMed ID: 34366665
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
[TBL] [Abstract][Full Text] [Related]
4. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
5. Cetuximab-conjugated iron oxide nanoparticles for cancer imaging and therapy.
Tseng SH; Chou MY; Chu IM
Int J Nanomedicine; 2015; 10():3663-85. PubMed ID: 26056447
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel thermal-sensitive multifunctional liposome with antibody conjugation to target EGFR-expressing tumors.
Liu KC; Arivajiagane A; Wu SJ; Tzou SC; Chen CY; Wang YM
Nanomedicine; 2019 Jan; 15(1):285-294. PubMed ID: 30391483
[TBL] [Abstract][Full Text] [Related]
7. Targeting EGFR-overexpressing tumor cells using Cetuximab-immunomicelles loaded with doxorubicin and superparamagnetic iron oxide.
Liao C; Sun Q; Liang B; Shen J; Shuai X
Eur J Radiol; 2011 Dec; 80(3):699-705. PubMed ID: 20810233
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy of glioblastoma stem-like cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles.
Kaluzova M; Bouras A; Machaidze R; Hadjipanayis CG
Oncotarget; 2015 Apr; 6(11):8788-806. PubMed ID: 25871395
[TBL] [Abstract][Full Text] [Related]
9. The role of exendin-4-conjugated superparamagnetic iron oxide nanoparticles in beta-cell-targeted MRI.
Zhang B; Yang B; Zhai C; Jiang B; Wu Y
Biomaterials; 2013 Jul; 34(23):5843-52. PubMed ID: 23642536
[TBL] [Abstract][Full Text] [Related]
10. The study on the preparation and characterization of gene-loaded immunomagnetic albumin nanospheres and their anti-cell proliferative effect combined with magnetic fluid hyperthermia on GLC-82 cells.
Zhang H; Hou X; Lin M; Wang L; Li H; Yuan C; Liang C; Zhang J; Zhang D
Drug Des Devel Ther; 2015; 9():6445-60. PubMed ID: 26719671
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-Conjugated Heparin-Coated Superparamagnetic Iron Oxide Nanoparticles for Combined Anticancer Drug Delivery and Magnetic Resonance Imaging.
Yang Y; Guo Q; Peng J; Su J; Lu X; Zhao Y; Qian Z
J Biomed Nanotechnol; 2016 Nov; 12(11):1963-74. PubMed ID: 29363935
[TBL] [Abstract][Full Text] [Related]
12. Renal inflammation: targeted iron oxide nanoparticles for molecular MR imaging in mice.
Serkova NJ; Renner B; Larsen BA; Stoldt CR; Hasebroock KM; Bradshaw-Pierce EL; Holers VM; Thurman JM
Radiology; 2010 May; 255(2):517-26. PubMed ID: 20332377
[TBL] [Abstract][Full Text] [Related]
13. [Molecular Image of Superparamagnetic Iron Oxide Nanopariticle Labeled with hATF in Colon Tumor Models].
Zhang S; Wang L; Chen L; Xu H; Wu Q; Bi F; Gao F; Xu F
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2015 Oct; 32(5):1067-74. PubMed ID: 26964313
[TBL] [Abstract][Full Text] [Related]
14. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
Wen M; Li B; Ouyang Y; Luo Y; Li S
Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
[TBL] [Abstract][Full Text] [Related]
15. Heparin-coated superparamagnetic iron oxide for in vivo MR imaging of human MSCs.
Lee JH; Jung MJ; Hwang YH; Lee YJ; Lee S; Lee DY; Shin H
Biomaterials; 2012 Jun; 33(19):4861-71. PubMed ID: 22475532
[TBL] [Abstract][Full Text] [Related]
16. Active targeting theranostic iron oxide nanoparticles for MRI and magnetic resonance-guided focused ultrasound ablation of lung cancer.
Wang Z; Qiao R; Tang N; Lu Z; Wang H; Zhang Z; Xue X; Huang Z; Zhang S; Zhang G; Li Y
Biomaterials; 2017 May; 127():25-35. PubMed ID: 28279919
[TBL] [Abstract][Full Text] [Related]
17. Radionuclide therapy using ¹³¹I-labeled anti-epidermal growth factor receptor-targeted nanoparticles suppresses cancer cell growth caused by EGFR overexpression.
Li W; Liu Z; Li C; Li N; Fang L; Chang J; Tan J
J Cancer Res Clin Oncol; 2016 Mar; 142(3):619-32. PubMed ID: 26573511
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a cell penetrating peptide modified superparamagnetic iron oxide and MRI detection of bladder cancer.
Ding C; Wu K; Wang W; Guan Z; Wang L; Wang X; Wang R; Liu L; Fan J
Oncotarget; 2017 Jan; 8(3):4718-4729. PubMed ID: 27902468
[TBL] [Abstract][Full Text] [Related]
19. Iron oxide nanoparticle-induced epidermal growth factor receptor expression in human stem cells for tumor therapy.
Chung TH; Hsiao JK; Hsu SC; Yao M; Chen YC; Wang SW; Kuo MY; Yang CS; Huang DM
ACS Nano; 2011 Dec; 5(12):9807-16. PubMed ID: 22053840
[TBL] [Abstract][Full Text] [Related]
20. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
